A clinical trial to look at the long-term safety of faricimab in patients with neovascular age-related macular degeneration (nAMD, also known as wet AMD)

A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Eye Disorder
Neovascular Age-related Macular Degeneration
Wet Age-Related Macular Degeneration
Age-Related Macular Degeneration

Results
Download

Study results

LPS GR42691 AVONELLE-X Final Results July 2025 English (PDF, 1.1 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A clinical trial to look at the long-term safety of faricimab in patients with neovascular age-related macular degeneration (nAMD, also known as wet AMD)

Study results

LPS GR42691 AVONELLE-X Final Results July 2025 English (PDF, 1.1 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A clinical trial to look at the long-term safety of faricimab in patients with neovascular age-related macular degeneration (nAMD, also known as wet AMD)

For the latest version of this information please go to www.forpatients.roche.com